Convera Executives Take the Stage at Money 20/20 USA to Share Vision for Secure, Borderless B2B Payments
27.10.2025 14:35:00 EET | Business Wire | Press release
Convera, a global leader in commercial payments, is on site at Money 20/20 USA this week as industry leaders gather to power the future of payments, fintech and financial services. From sessions on the global stage to the unveiling of dynamic data, Convera spotlights its mission to reimagine the future of business payments on a global scale.
Convera is also sponsoring Association for Financial Professionals (AFP) 2025 where Convera’s CFO, Michael Bourque, and VP, Global Head of Treasury, David Teirney, will share the stage with Alacriti to explore the importance of leveraging a single platform for domestic and international payments, digital-first connectivity, and the benefits of a one-stop-shop provider. Come visit booth #644 and register to attend Convera Live Boston After Dark event to network and connect live with industry peers.
“We’re reimagining the future of cross-border payments for businesses of any size and are thrilled to share our data-driven insights at Money 20/20, surrounded by industry peers who share the same sentiment,” said Patrick Gauthier, CEO, Convera. “We believe that collaboration is the key to purposeful innovation and learning from each other fuels Convera’s ability to continue to perfect money movement for businesses across the globe.”
Additionally, Convera is launching its annual Are You Ready for 2026? report during these events, which delivers a sharp, forward-looking analysis of the forces redefining global finance including:
- Why central bank independence is under threat and what this means for FX markets.
- How tariff-led fragmentation is reshaping supply chains and pricing dynamics.
- The slow fade of the US dollar and what comes next for global currencies.
- Actionable insights to help you navigate uncertainty and unlocking opportunity.
Heading to Money 20/20? Don’t miss Convera’s executive sessions or connect with the team:
- Building AI-Driven Infrastructure to Accelerate Cross-Border Payments Innovation
Monday, Oct. 27, 10:45 AM – 11:15 AM
Led by Sudipto Das, VP, Engineering, Convera, this session will explore how generative AI is transforming the technical backbone of cross-border payments and will showcase how AI-powered knowledge pipelines break down silos by delivering contextual insights across departments.
- Using an AI-Driven Approach to Safeguard Commercial Relationships
Tuesday, Oct. 28, 10:30 AM – 11:00 AM
Led by Sara Madden, CISO, Convera, this session will demonstrate how AI as infrastructure is not just a tool, but a strategic enabler for securing trust, mitigating risk, and building resilient commercial relationships in the age of digital B2B payments.
- Global Payments Race: Redefining B2B and Fintech Strategies in a Borderless Era
Tuesday, Oct. 28, 4:15 PM – 4:45 PM
Led by Patrick Gauthier, CEO, Convera, this session will focus on how B2B payment practitioners can navigate this fast-evolving ecosystem, including the critical role of partnerships and “coopetition,” the impact of regulatory clarity on cross-border flows, and the importance of interoperability among increasingly instant and borderless payments.
To connect with Convera at Money 20/20 and to learn more about its cross-border payments capabilities, stop by the Converge Stage for a conversation.
For those who can’t make it to Money 20/20, learn more about how Convera is reimagining the future of business payments at an upcoming Convera Live event, touring cities around the globe in 2025 and 2026. Visit Convera Live to find an event near you.
Additional Resources
- Learn how Convera makes smart money moves
- Follow Convera on LinkedIn and Instagram
- Tune in to the Converge Podcast as we shape the future of finance
- Read Convera’s blog for the latest market insights and FX news
- Look out for Convera at other upcoming industry shows
- Sign up to attend a Convera Live roadshows
About Convera
Convera is a global leader in commercial payments. With an unrivaled regulatory footprint and a financial network spanning more than 140 currencies and 200 countries and territories, Convera is reimaging the future of business payments. We combine tech-led payment solutions with deep expertise in foreign exchange, risk management, and compliance. From small businesses to CFOs and treasurers, we’re helping our customers grow with confidence. Convera makes business payments simple, smart, and secure.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251027971191/en/
Contacts
pr@convera.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 15:00:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.
Fortegra Completes Acquisition by DB Insurance29.5.2026 23:30:00 EEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 23:01:00 EEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom